Click here to go to back to the top of the page.

Therapeutic
Areas of Focus

We are advancing novel science and accelerating potential breakthrough therapies with the goal of delivering transformative medicines and vaccines, and possibly even cures, to patients in need. We focus our efforts in areas where we believe we are best positioned to utilize our expertise and bring unique, needed therapies to patients. More and more, our scientists are reaching into a dynamic R&D ecosystem to find the right partners to improve and accelerate our efforts. This focus and effort are helping to drive our long-term growth.

Patents Issued to Pfizer in 2015
129*
In the U.S.
1,807*
Outside of the U.S.

* Includes Hospira patents. Does not include licensed-in patents.

Focusing on Science and Patient Impact

Oncology

We're investigating precision-guided therapies targeting novel signaling and epigenetic pathways, and cancer immunotherapies aimed at modulating the immune system.

I'm Working On...
Click to play the video.
Puja Sapra
Senior Director, Oncology Research
Watch Video
I'm Working On...
Click to play the video.
Puja Sapra
Senior Director, Oncology Research
Watch Video
I'm Working On...
Click to play the video.
Jeremy Bartlett
Associate Research Fellow, Drug Product Design
Watch Video
I'm Working On...
Click to play the video.
Jeremy Bartlett
Associate Research Fellow, Drug Product Design
Watch Video
Vaccines

We are tackling some of the most deadly pediatric, adult and adolescent infectious diseases, as well as evaluating therapeutic vaccines across a variety of cancer types.

I'm Working On...
Click to play the video.
Karin Joos
Senior Director, Biology, Vaccine Immunotherapeutics and Head of Cancer Vaccine Development
Watch Video
I'm Working On...
Click to play the video.
Karin Joos
Senior Director, Biology, Vaccine Immunotherapeutics and Head of Cancer Vaccine Development
Watch Video
I'm Working On...
Click to play the video.
Alejandra Gurtman
Program Lead, Staph Aureus Vaccine
Watch Video
I'm Working On...
Click to play the video.
Alejandra Gurtman
Program Lead, Staph Aureus Vaccine
Watch Video
Neuroscience
& Pain

We are exploring Parkinson's, Alzheimer's and Huntington's disease, as well as conducting research into trans-diagnostic domains, where we explore how cognition, anxiety and motivation correlate to the manifestation of a neuropsychiatric disorder, and their impact on a patient's quality of life.

I'm Working On...
Click to play the video.
Anabella Villalobos
Vice President, Neuroscience and Pain Medicinal Chemistry
Watch Video
I'm Working On...
Click to play the video.
Anabella Villalobos
Vice President, Neuroscience and Pain Medicinal Chemistry
Watch Video
I'm Working On...
Click to play the video.
David Gray
Senior Director, Parkinson's Drug Development Team Leader
Watch Video
I'm Working On...
Click to play the video.
David Gray
Senior Director, Parkinson's Drug Development Team Leader
Watch Video
I'm Working On...
Click to play the video.
Matt Howe
Postdoctoral Research Fellow, Neuroscience Research Unit
Watch Video
I'm Working On...
Click to play the video.
Matt Howe
Postdoctoral Research Fellow, Neuroscience Research Unit
Watch Video
Click to play the video.
A View into Treating Brain Conditions
Watch Video
Click to play the video.
A View into Treating Brain Conditions
Watch Video
Cardiovascular
& Metabolic

Our clinical-stage pipeline of potential therapies for patients covers a range of metabolic and cardiovascular risk factors, as well as exploring the areas of heart failure and nonalcoholic liver inflammation and damage.

I'm Working On...
Click to play the video.
Albert Kim
Global Clinical Lead, Cardiovascular and Metabolic Disease
Watch Video
I'm Working On...
Click to play the video.
Albert Kim
Global Clinical Lead, Cardiovascular and Metabolic Disease
Watch Video
I'm Working On...
Click to play the video.
Ann Marie Richard
Principal Scientist, Metabolic Disease
Watch Video
I'm Working On...
Click to play the video.
Ann Marie Richard
Principal Scientist, Metabolic Disease
Watch Video
Click to play the video.
Pfizer's Legacy and Expertise in Cardiovascular Diseases
Watch Video
Click to play the video.
Pfizer's Legacy and Expertise in Cardiovascular Diseases
Watch Video
Immunology
& Inflammation

We are looking to transform the treatment of chronic inflammatory diseases such as rheumatoid arthritis and gastrointestinal disorders, while investigating potential therapies with application in medical dermatology.

I'm Working On...
Click to play the video.
Iain Kilty
Senior Director, Rheumatology and Dermatology
Watch Video
I'm Working On...
Click to play the video.
Iain Kilty
Senior Director, Rheumatology and Dermatology
Watch Video
I'm Working On...
Click to play the video.
Janet Buhlmann
Senior Principal Scientist, Immunology and Autoimmunity
Watch Video
I'm Working On...
Click to play the video.
Janet Buhlmann
Senior Principal Scientist, Immunology and Autoimmunity
Watch Video
Rare Disease

Our researchers in rare disease are working to unlock the scientific opportunity of gene therapy for people living with hemophilia, as well as investigating potential therapies for blood and neuromuscular diseases, which are devastating to patients, their families and the larger community.

I'm Working On...
Click to play the video.
Joseph Nabhan
Principal Scientist, Rare Disease Research Unit
Watch Video
I'm Working On...
Click to play the video.
Joseph Nabhan
Principal Scientist, Rare Disease Research Unit
Watch Video
I'm Working On...
Click to play the video.
Kelly Knee
Principal Scientist, Rare Disease
Watch Video
I'm Working On...
Click to play the video.
Kelly Knee
Principal Scientist, Rare Disease
Watch Video
Biosimilars

With our acquisition of Hospira, we are now a leading global biosimilars company with a robust pipeline, best-in-class development capabilities and extensive real-world commercialization experience. We are working hard to extend that leadership by advancing high quality biosimilars to address the evolving needs of patients, payers and health systems.

I'm Working On...
Click to play the video.
Lisa Skeens
Head of Global Regulatory Affairs, Global Established Pharma
Watch Video
I'm Working On...
Click to play the video.
Lisa Skeens
Head of Global Regulatory Affairs, Global Established Pharma
Watch Video

Expanding the R&D Ecosystem

Our strategy looks to foster collaboration across the biomedical ecosystem to deliver innovation to patients. We are working to bring the best science, wherever it resides, into our efforts to find and develop needed therapies.

We attempt to establish flexible collaborations that can have an amplifying and accelerating effect — optimizing shared assets and capabilities and making it possible to pursue more research avenues or de-risking the earlier stage research that may provide the foundation for true medical breakthroughs. In these new forms of collaboration, we are sharing in the risks and rewards and attempting to expedite the pace of innovation and enhance the R&D ecosystem for the benefit of patients.

Back to Top